Zhejiang Jingxin Pharmaceutical Co., Ltd.
2025 Internal Control Self-Evaluation Report
To All Shareholders of Zhejiang Jingxin Pharmaceutical Co., Ltd.:
In accordance with the "Basic Norms for Enterprise Internal Control" and its supporting guidelines, as well as other internal control regulatory requirements (hereinafter referred to as the "Internal Control Norms System"), and combined with the internal control system and evaluation methods of Zhejiang Jingxin Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company"), based on daily supervision and special supervision of internal controls, the Company's Board of Directors has evaluated the effectiveness of internal controls as of December 31, 2025.
I. Important Statement
In accordance with the requirements of the Internal Control Norms System, establishing and effectively implementing internal controls, evaluating their effectiveness, and truthfully disclosing the internal control evaluation report are the responsibilities of the Company's Board of Directors. The Audit Committee supervises the establishment and implementation of internal controls by the Board of Directors. The management is responsible for organizing and leading the daily operation of the Company's internal controls. The Company's Board of Directors, directors, and senior management guarantee that the content of this report is free from any false records, misleading statements, or material omissions, and shall bear individual and joint legal liability for the truthfulness, accuracy, and completeness of the report's content.
The objective of the Company's internal control is to reasonably ensure that operations are legal and compliant, assets are safe, financial reports and related information are true and complete, and to improve operational efficiency and effectiveness, thereby promoting the realization of development strategies. Due to the inherent limitations of internal control, it can only provide reasonable assurance for the achievement of these objectives. Furthermore, changes in circumstances may render internal controls inappropriate, or reduce the degree of compliance with control policies and procedures. Therefore, inferring the future effectiveness of internal controls based on the results of the internal control evaluation carries certain risks.
II. Internal Control Evaluation Conclusion
Based on the identification of material weaknesses in the Company's financial reporting internal controls, as of the benchmark date of the internal control evaluation report, there are no material weaknesses in financial reporting internal controls. The Board of Directors believes that the Company has maintained effective financial reporting internal controls in all material aspects in accordance with the requirements of the Internal Control Norms System and relevant regulations.
Based on the identification of material weaknesses in the Company's non-financial reporting internal controls, as of the benchmark date of the internal control evaluation report, the Company has not found any material weaknesses in non-financial reporting internal controls.
No factors have occurred between the benchmark date of the internal control evaluation report and the date of issuance of the internal control evaluation report that have affected the conclusion on the effectiveness of internal control evaluation. The internal control system established by the Company has no material weaknesses in terms of completeness, compliance, and effectiveness.
III. Internal Control Evaluation Work